FIELD: medicine, narcology. SUBSTANCE: the present innovation deals with detecting opium narcomania-suffering persons. One should detect patient's serumal immunoreactivity specified by antiopium antibodies and antigen- specific antiantibodies in comparison with normal serum and at increased immunoreactivity specified by antiopium antibodies or antigen-specific antiantibodies, or that and another by 50% one should conclude upon opium narcomania, and at the ratio of 1st immunoreactivity to 2nd one being above 0.8 it is possible to conclude upon narcomania duration to be more than for last 4-6 mo. EFFECT: higher simplicity and accuracy of detection. 1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING NERVOUS SYSTEM PATHOLOGY RISK GROUP BY MEANS OF SCREENING AND HEALTH STATE MONITORING OF PEOPLE SUFFERING FROM NEUROPSYCHICAL DISEASES | 2003 |
|
RU2259567C2 |
| PROCEDURE EVALUATING DISTURBANCES IN DEVELOPMENT OF FETUS | 2002 |
|
RU2208791C1 |
| METHOD FOR DETERMINING NEUROPSYCHIC DISEASES DEVELOPMENT RISK DEGREE | 1997 |
|
RU2147128C1 |
| METHOD FOR CARRYING OUT MONITORING OF DIABETES MELLITUS PATIENTS STATE AND NEUROLOGICAL AND VASCULAR COMPLICATIONS DEVELOPMENT | 2004 |
|
RU2291437C2 |
| METHOD FOR PERFORMING SCREENING EXAMINATION OF WOMEN OF PRODUCTIVE AGE BY MEANS OF ELI-P TEST SYSTEM TO PREDICT EMBRYO/FETUS DEVELOPMENT AND BIRTH OF HEALTHY OR ANOMALOUS BABY | 1995 |
|
RU2107913C1 |
| METHOD FOR SPECIFIC PROPHYLAXIS OF ALEUTIAN DISEASE IN MINKS | 2001 |
|
RU2218354C2 |
| METHOD FOR SCREENING OF NEURO-MENTAL DISEASES | 1992 |
|
RU2045759C1 |
| METHOD FOR DETECTING RISK GROUPS IN DEVELOPING NERVOUS-PSYCHIC DISEASES | 2002 |
|
RU2218569C1 |
| METHOD FOR PREPARING ANTICANCER AGENT FOR TREATING SOLID TUMOURS | 2012 |
|
RU2521193C2 |
| METHOD FOR PREDICTING THE FLOW OF NERVOUS-PSYCHIC DISEASES | 2003 |
|
RU2258934C9 |
